- Carcinoid and Neuroendocrine Cancer Team
- Gastrointestinal and Colorectal Cancer Team
- Medical Oncology
Professor of Medicine
Yale University, School of Medicine, New Haven, Conn.
Stanford University Hospital, Palo Alto, Calif.
Medical Oncology, Stanford University Hospital, Palo Alto, Calif.
National Cancer Institute, NIH, Bethesda, Md.
Certifications or Special training
American Board of Internal Medicine
American Board of Internal Medicine, Medical Oncology
As Director of Neuroendocrine and GI Oncology and Director of Clinical Research, Edward M. Wolin
brings a robust research program to Markey, including multiple clinical trials. His research
efforts focus on finding treatments which are more effective and less toxic, including pasireotide,
lanreotide, everolimus, other m-tor inhibitors, targeted radiation including peptide receptor
radiotherapy with Lu-177, anti-angiogenic drugs, novel targeted biologic anti-cancer treatments,
and targeted treatment of liver metastases. Wolin's research is also directed at development of
new imaging and diagnostic procedures for carcinoid/neuroendocrine tumors.
Wolin has previously been on the faculties of University of California in Los Angeles,
Cedars-Sinai Medical Center, and Washington University in St. Louis.
Research Publications on NCBI PubMed
Carcinoid and Neuroendocrine Cancer
Gastrointestinal and Colorectal Cancer